MTMadison Y. Taylor

Madison Y. Taylor

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Madison Y. Taylor has a total of 55 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Influence of Menstrual Cycle Phase on the Physiological and Perceptual Responses to Low‐Intensity Continuous and High‐Intensity Interval Sessions in Endurance Trained Women: The FENDURA Project

    by Madison Y. Taylor, Heleen Docter, Klavs Madsen, Vilde Sophie Sogn Tjernes, Boye Welde, Bente Morseth, Thomas Haugen, Øyvind Sandbakk, John O. Osborne, Dionne A. Noordhof

    The influence of the menstrual cycle (MC) on the acute responses to endurance training remains unclear. This study aimed to investigate the effect of the MC on the physiological and perceptual responses to standardized low‐intenstiy continuous (LIT) and high‐intensity interval sessions (HIT). Naturally menstruating endurance‐trained women performed a standardized LIT ( n = 23) and/or HIT ( n = 23) session during the early‐follicular (EFP), ovulatory (OP), and mid‐luteal (MLP) phases of 2 MCs. Physiological (i.e., oxygen uptake (O 2 ), heart rate (HR), and blood lactate concentration (BLa)) and perceptual variables (i.e., rating of perceived exertion (RPE) and mood state) were measured. MC phases were determined using urinary ovulation kits and verified with serum hormone analysis. Non‐eumenorrheic MCs were excluded from analysis. During LIT and HIT, ventilation (VE) was higher in MLP than OP ( p < 0.001) and BLa was slightly higher in EFP than OP (LIT, p = 0.004, HIT, p = 0.001). During HIT, O 2 ( p = 0.025) and HR ( p = 0.036) were slightly higher during MLP than OP. RPE was slightly higher in EFP than OP in the LIT ( p = 0.036) and HIT ( p < 0.001). Vigor ( p < 0.001) and tension ( p = 0.036) were highest in EFP. No phase by time interactions were observed for any of the outcome variables throughout either session type ( p > 0.05). MC phase had a modest effect on several physiological and perceptual measures during LIT and HIT. However, the between‐phase differences were small and no clear trends emerged across variables to indicate that the overall demands of a LIT or HIT session would be substantially altered in any one particular MC phase.


  • Research With Female Athletes: Choosing the Best Tools for the Job

    by Kerry McGawley, Madison Y. Taylor, Natalie Brown, Sophie E. Harrison, Georgie Bruinvels, Claire E. Badenhorst


  • Open Access

    Prevalence of Hormonal Contraceptive Use and Self‐Reported Symptomatic Experiences Attributed to the Menstrual Cycle or Hormonal Contraceptive Use in Norwegian Women: The Effect of Training Categories and Age Groups ‐ The FENDURA Project

    by John Owen Osborne, Jonas H. Storvand, Tina P. Engseth, Guro S. Solli, Bente Morseth, Madison Y. Taylor, Boye Welde, Kirsty J. Elliott‐Sale, Erik P. Andersson, Øyvind Sandbakk, et al.

    The aims of the current study were to (1) report the prevalence of hormonal contraceptive (HC) use among Norwegian women across different training categories and age groups; (2) compare the frequency and severity of cycle‐related symptoms across differing training categories and age groups; and (3) describe the bleeding pattern and prevalence of menstrual disorder/disturbances among non‐HC users. A sample of 2059 Norwegian women completed a survey reporting: weekly training volume; current HC usage, type, and reasons for use; cycle‐related symptom frequency and severity; and the prevalence of menstrual disorders/disturbances. Respondents were categorized by age (youth: 13–20; young adults: 21–30; older adults: 31–50 years) and training category (minimal: 0; low: < 5; moderate: 5–9; high: ≥ 9 h·week−1). Half (51.6%) of respondents reported current HC usage, predominantly long‐acting reversible contraception or combined oral contraceptives. Young adults had the highest prevalence of HC use (62.7%) compared to youth (48.4%) and older adults (43.8%), although no differences in usage were seen across training categories. HC users reported fewer and less severe cycle‐related symptoms compared to non‐users. A third (30.8%) of non‐HC users had experienced a menstrual disorder/disturbance, with no significant differences observed across training categories or age groups. In conclusion, HC use is widespread among Norwegian women, with no differences between training categories. This similar HC prevalence suggests that HC research conducted in female cohorts may be generalizable, independent of training category. However, attention should be paid to participants' age due to differences in HC use between age groups.


  • Open Access

    Running Economy After a Low‐ and High‐Intensity Training Session in Naturally Menstruating Endurance‐Trained Female Athletes: The FENDURA Project

    by Heleen Docter, Madison Taylor, Anna Lena Müller, Jos J. de Koning, Øyvind B. Sandbakk, John O. Osborne, Dionne A. Noordhof

    The ability to maintain running economy is generally evaluated during a long continuous exercise bouts, and it is unclear whether the menstrual cycle phase acts as a confounder. The first aim of this study was to evaluate the ability to maintain running economy during typical 1‐h low‐ (LIT) and high‐intensity training (HIT) sessions in female athletes. The second aim was to investigate whether menstrual cycle phase affected the ability to maintain running economy. Naturally menstruating endurance‐trained females performed three LIT ( n = 16) (45%–55% of the maximal velocity achieved during the maximal incremental test) and/or three HIT sessions ( n = 17) (5 × 4 min at 80% of the maximal velocity achieved during the maximal incremental test) during three distinct menstrual cycle phases: early follicular, ovulatory, and mid luteal. Running economy was determined before and after each session. Running economy, expressed as energy cost (before: 1.34; after: 1.34 kcal/kg/km, p = 0.797) and oxygen cost (before: 272, after: 273 mL/kg/min, p = 0.348), was not significantly different before versus after the LIT session. Energy cost (before 1.33; after: 1.34 kcal/kg/km, p = 0.130) was not significantly different before versus after the HIT session, but oxygen cost (before: 269; after: 274 mL/kg/km, p < 0.003) was slightly higher after the session. Menstrual cycle phase did not confound the ability to maintain running economy. Running economy can be maintained during a typical 1‐h LIT session. The ability to maintain running economy during a typical HIT session depends on the expression used; energy cost was unaffected, while oxygen cost may be slightly increased after HIT sessions.


  • Top Cited Papers
    Open Access

    Why We Must Stop Assuming and Estimating Menstrual Cycle Phases in Laboratory and Field-Based Sport Related Research

    by Kirsty Jayne Elliott-Sale, Marco Altini, Patricia Doyle-Baker, Eva Ferrer, Tessa Rose Flood, Rachel Harris, Franco Milko Impellizzeri, Xanne Janse de Jonge, Katrine Okholm Kryger, Gary Lewin, et al.

    The increased growth, popularity, and media interest in women’s sport has led to calls for greater prioritisation of female-specific research and innovation. In response, science and medicine researchers have increased the volume of sport-related studies investigating female-specific matters, such as the menstrual cycle. Whilst the accelerated rate of published studies with female participants is welcome, the emerging trend of using assumed or estimated menstrual cycle phases to characterise ovarian hormone profiles is a significant concern. Replacing direct measurements of key characteristics of the menstrual cycle (e.g. the surge in luteinising hormone prior to ovulation via urine detection and sufficient luteal phase progesterone via blood or saliva sampling) with assumptions or estimates (i.e. no measurements) is proposed to be a pragmatic and convenient way of generating data, particularly in field-based research (i.e. elite athlete environments), where time, resources, and athlete availability are sometimes constrained. Using assumed or estimated phases, however, amounts to guessing the occurrence and timing of ovarian hormone fluctuations and risks potentially significant implications for female athlete health, training, performance, injury, etc., as well as resource deployment. The positive intentions of researchers and scientific journals in this space are not in question. The aim of this Current Opinion is to explain why using assumed or estimated menstrual cycle phases is an approach that has little scientific basis and lacks the rigour and appropriate methodological quality to produce valid and reliable data. In doing so, we provide evidence-based responses to common speculation points and offer recommendations for future research.


  • Open Access

    Influence of menstrual- and hormonal contraceptive cycle on self-reported symptom severity and recovery measures across an annual season in female endurance athletes: The FENDURA project

    by Tina P. Engseth, John O. Osborne, Guro S. Solli, Bente Morseth, Erik P. Andersson, Virginia De Martin Topranin, Madison Taylor, Dionne A. Noordhof, Øyvind Sandbakk, Boye Welde

    This longitudinal study investigated 1) differences in self-reported cycle-related symptom severity and recovery measures (sleep quality, readiness to train, resting heart rate) between pre-bleeding, bleeding, and non-bleeding days in athletes using/not using hormonal contraception (HC); 2) associations between symptom severity and recovery measures. Fifty-eight female endurance athletes recorded recovery measures, perceived symptom severity, and menstruation/withdrawal (bleeding) days for one year. Athletes were grouped as: intrauterine system (IUS)-, implant-, progestin-only oral contraceptive (POC)-, combined oral contraceptive (COC)- and non-HC users. All groups reported higher symptom severity during bleeding compared to pre-bleeding and non-bleeding days (both p < .001), while implant users reported less severe symptoms than IUS (p < .001) and non-HC users (p = .008). Perceived sleep quality was lower during pre-bleeding compared to bleeding days (p < .001) for all groups. However, IUS users reported higher sleep quality (p = .039) and physical readiness-to-train (p = .010) than non-HC users. Symptom severity was negatively associated with sleep quality and physical readiness-to-train (both p < .050). Pre-bleeding days and cycle-related symptom severity were found to negatively influence self-reported recovery measures in both HC- and non-HC users. Therefore, athletes and their support staff are advised to prioritize symptom management and the adjustment of recovery strategies on an individual basis throughout the athletes' cycles.


  • Influence of Menstrual-Cycle Phase on Sleep and Recovery Following High- and Low-Intensity Training in Eumenorrheic Endurance-Trained Women: The Female Endurance Athlete Project

    by Madison Y. Taylor, Maria Hrozanova, Liv Nordengen, Øyvind Sandbakk, John O. Osborne, Dionne A. Noordhof

    Purpose: To investigate the influence of menstrual-cycle (MC) phase on objective sleep and perceived recovery following high- (HIT) and low-intensity training (LIT) in endurance-trained women. Methods: Fifteen naturally menstruating, endurance-trained women completed standardized HIT and LIT sessions during the early follicular phase (EFP), ovulatory phase (OP), and midluteal phase (MLP) of 2 MCs. Overnight sleep was monitored using a Somnofy sleep monitor after each training session, and perceived recovery was assessed after 24 hours using self-report scales. MC phases were determined using the 3-step method, and noneumenorrheic MCs were retrospectively excluded from analysis. Results: MC phase had a main effect on wake after sleep onset (P ≤ .001), with higher values in MLP (33 [22] min) than EFP (22 [19] min, P = .043) and OP (14 [9] min, P = .001), sleep efficiency (P = .033), with lower values in MLP (87% [6%]) than OP (90% [8%], P = .047), and light sleep (P = .023) with higher values in MLP (59% [6%]) than EFP (54% [7%], P = .037). Session type had a main effect on perceived recovery (P < .018) and perceived muscle soreness (P = .007), indicating lower perceived recovery and higher perceived muscle soreness following HIT compared to LIT (P < .001, P = .018, respectively). No interactions were found between MC phase and session type for any of the measured variables. Conclusions: Objective sleep quality, but not perceived recovery, was influenced by MC phase, as indicated by small impairments to multiple indices of objective sleep during MLP. There were no interactions between MC phase and session type, indicating that the effect of MC on sleep and recovery is consistent regardless of session type.


  • Agreement Between the 2- and 3-Step Methods for Identifying Subtle Menstrual Disturbances

    by Dionne A. Noordhof, Madison Y. Taylor, Virginia De Martin Topranin, Tina P. Engseth, Øyvind Sandbakk, John O. Osborne

    Recent methodological recommendations suggest the use of the “3-step method,” consisting of calendar-based counting, urinary ovulation testing, and serum blood sampling, for the identification of subtle menstrual disturbances (SMDs). However, the use of the 3-step method is not always feasible, so a less demanding combination of calendar-based counting and urinary ovulation testing, that is, the 2-step method, may be a viable alternative. Purpose : To investigate the agreement between the 2- and 3-step methods for the detection of SMDs. Methods : Menstrual cycles (MCs, 98) of 59 athletes were assessed using the 2- and 3-step methods. Regular-length MCs (ie, ≥21 and ≤35 d) were classified as either having no SMD (luteal phase length ≥10 d, midluteal progesterone concentration ≥16 nmol·L −1 , and being ovulatory) or having an SMD (eg, short luteal phase [−1 ], or being anovulatory). Method agreement was assessed using the McNemar test and Cohen kappa ( κ ). Results : Substantial agreement was observed between methods ( κ = .72; 95% CI, .53–.91), but the 2-step method did not detect all MCs with an SMD, resulting in evidence of systematic bias ( χ 2 = 5.14; P = .023). The 2-step method detected 61.1% of MCs that had an SMD ([51.4, 70.8]), as verified using the 3-step method, and correctly identified 100% of MCs without an SMD. Conclusions : MCs classified as being disturbed using the 2-step method could be considered valid evidence of SMDs. However, MCs classified without SMDs do not definitively confirm their absence, due to the proven underdetection via the 2-step method.


  • Menstrual Cycle Phase Has No Influence on Performance-Determining Variables in Endurance-Trained Athletes: The FENDURA Project

    by Madison Y. Taylor, John O. Osborne, Virginia DE Martin Topranin, Tina P. Engseth, Guro S. Solli, Ditta Valsdottir, Erik Andersson, Gina F. Øistuen, Ingrid Flatby, Boye Welde, et al.

    Female athletes frequently perceive performance changes throughout the menstrual cycle (MC). However, if and how the MC influences performance-determining variables remain unclear. Purpose: This study aimed to investigate the effect of the MC and endogenous sex hormone concentrations on performance-determining variables in three distinct MC phases in endurance-trained females. Methods: Twenty-one eumenorrheic trained/highly trained endurance athletes completed a standardized test battery during the early follicular phase (EFP), ovulatory phase (OP), and midluteal phase (MLP) for either one (n = 7) or two test cycles (n = 14). MC phases were determined using calendar-based counting, urinary ovulation testing, and verified with serum hormone analysis. MCs were retrospectively classified as eumenorrheic or disturbed. Disturbed MCs were excluded from analysis. The test battery consisted of 4–6 × 5-min submaximal stages with stepwise speed increases, a 30-s all-out double-poling ski ergometer test, and a maximal incremental treadmill running test. Results: At a group level, there was no effect of MC phase or the serum concentrations of estrogen and progesterone on peak oxygen uptake (V̇O2peak), oxygen uptake at 4 mmol·L−1 blood lactate concentration, time to exhaustion, running economy, or mean 30-s power output (MPO30s). Serum testosterone concentration was positively associated with MPO30s (P = 0.016). Changes in V̇O2peak from EFP to MLP were inconsistent between individuals and across cycles. Conclusions: None of the measured performance-determining variables were influenced by MC phase or serum estrogen or progesterone concentrations. Although some individual patterns could be observed, there was no indication that any single MC phase is consistently associated with improved or impaired V̇O2peak on a group level.